Artificial Pancreas State Estimation for Low-Load Insulin Control

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing glucose control systems for diabetes management suffer from computational demands, inaccuracies in predictive models, delays in insulin delivery, and reliance on approximate human physiology models, leading to suboptimal insulin dosage and increased risk of hypoglycemia.

Innovation Solution

An artificial pancreas control system using an adaptive filter scheme and Linear Quadratic (LQ) methodology to estimate physiological states from real-time glucose measurements, optimizing insulin dosing recommendations through a dynamic model and Kalman filter to minimize quadratic cost functions.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If Model Predictive Control (MPC) is used to provide glucose control based on prediction, then glucose control accuracy is improved, but computational demand increases significantly

Engineering Contradiction:
Improveglucose control accuracyVSAvoidcomputational demand
Core Design Contradiction:
Measurement precisionVSUse of energy by moving object

Solution Approach 1:

The patent transforms the complex MPC problem into a simpler Linear Quadratic (LQ) control problem by changing the mathematical parameters and structure. Instead of using full predictive models with multiple constraints and objectives, the invention uses a simplified cost function with quadratic terms that can be solved analytically, reducing computational complexity while maintaining control accuracy.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The patent extracts only the essential elements needed for glucose control from the full MPC framework. By removing unnecessary predictive components and focusing on the core control objective (minimizing glucose deviation from target), the system achieves adequate performance with significantly reduced computational burden.

Inventive Principle:
Principle #2Taking out (Extraction)

2Speed

If control updates are performed at high frequency to improve responsiveness, then glucose control responsiveness is improved, but computational capacity requirements increase

Engineering Contradiction:
Improvecontrol update frequencyVSAvoidcomputational capacity requirements
Core Design Contradiction:
SpeedVSDevice complexity

Solution Approach 1:

The patent changes the control formulation from a complex constrained optimization problem to an unconstrained LQ problem with a simple quadratic cost function. This parameter transformation enables analytical solutions that can be computed rapidly at high update frequencies without requiring substantial computational resources.

Inventive Principle:
Principle #35Parameter changes

3Device complexity

If inaccurate predictive models are used to simplify control computation, then device complexity is reduced, but glucose control accuracy deteriorates

Engineering Contradiction:
Improvemodel complexityVSAvoidglucose control accuracy
Core Design Contradiction:
Device complexityVSMeasurement precision

Solution Approach 1:

The patent uses a simplified linear quadratic cost function with carefully chosen parameters that capture the essential glucose-insulin dynamics. By transforming the control objective into a mathematical form with specific parameter structures (quadratic terms, weighting factors), the system achieves accurate control results without requiring complex predictive models.

Inventive Principle:
Principle #35Parameter changes

Data Source

PatentUS12533464B2LQG artificial pancreas control system and related method
Publication Date: 2026.01.27 UNIV OF VIRGINIA PATENT FOUND
  • US12533464B2 patent drawing
  • US12533464B2 patent drawing
  • US12533464B2 patent drawing

AI summary

The invention relates to a methods and systems for determining an insulin dosing recommendation. The invention employs Linear Quadratic methodology to determine the insulin dosing recommendation based on a patient's present physiological state, which is estimated by an adaptive filter methodology employing a dynamic model, which utilizes real time measurements of blood glucose concentration.